SK Biopharmaceuticals Reports 20.2% Rise in Q2 Net Profit to 29.5 Billion Won
Seoul: SK Biopharmaceuticals Co. on Tuesday reported a significant increase in its second-quarter net profit, reaching 29.5 billion won (US$21.3 million), marking a 20.2 percent